Live Analyst Rating Changes 23582 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Steven Silver
ARG

Steven Silver

Argus Research
Wall Street Analyst
★★★★★
#234
on 13Foresight · ranked by our own returns
79%
Success Rate
+20.7%
Average Return
11 of 14 calls profitable · +12.9% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 79% of Steven Silver's ratings turned a profit when each position was held for 1 year — averaging +20.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

8 Buy 5 Hold 0 Sell
Steven's Stock Coverage 11 ratings · 2026-08-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
SPCX
SpaceX
 Aug 06, 2026 BUY Strong Buy
+81.1% avg upside
29 analysts
$160.00
20.12% Upside
 +15.8% ·
DXCM
Dexcom
 Aug 03, 2026 BUY Strong Buy
+19.0% avg upside
32 analysts
$96.00
7.28% Upside
 +2.4% ·
CVS
CVS Health
 May 13, 2026 BUY Strong Buy
+12.8% avg upside
39 analysts
$104.00
11.15% Upside
 -4.1% ·
BAX
Baxter International
 May 08, 2026 HOLD Buy
+21.2% avg upside
23 analysts
 — +52.9% ·
CAH
Cardinal Health
 May 05, 2026 BUY Strong Buy
-16.8% avg upside
29 analysts
$248.00
3.29% Upside
 +19.6% ·
ITGR
Integer Holdings
 Oct 24, 2025 HOLD Buy
-18.1% avg upside
16 analysts
 — +71.5% ·
TZOO
Travelzoo
 May 11, 2022 BUY Strong Buy
+160.6% avg upside
8 analysts
$19.00
166.88% Upside
 +39.2% ·
THC
Tenet Healthcare
 Jun 13, 2014 HOLD Strong Buy
-8.5% avg upside
27 analysts
 — +10.3% ·
ALNY
Alnylam Pharma
 Jan 27, 2014 BUY Strong Buy
+46.8% avg upside
51 analysts
 — +17.8% ·
GILD
Gilead Sciences
 Dec 09, 2013 BUY Strong Buy
-12.1% avg upside
66 analysts
$94.00
30.73% Downside
 +40.9% ·
BKD
Brookdale Senior Living
 Oct 22, 2010 BUY Strong Buy
+8.9% avg upside
11 analysts
 — -22.1% ·
🔒 6 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Steven Silver — Frequently Asked Questions
How accurate are Steven Silver's stock ratings?
Based on the calls 13Foresight could measure, about 79% of Steven's ratings were profitable over a one-year hold, with an average return of +20.7% per rating, or +12.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Steven ranked on 13Foresight?
Steven Silver is currently ranked #234 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Steven cover?
Steven most recently has ratings on SPCX, DXCM, CVS, BAX, CAH, ITGR, TZOO, THC, ALNY, GILD, BKD. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.